Back to Top Skip to main content Skip to sub-navigation

DoD Leverages GEIS Respiratory Surveillance to Respond to COVID-19

Image of Three men in a pig pen taking samples. Click to open a larger version of the image. Staff from the U.S. Navy Medical Research Unit 6, better known as NAMRU-6, perform sampling on swine and swine workers in Peru. This testing helps monitor the transmission of potential respiratory pathogens.

Recommended Content:

Armed Forces Health Surveillance Division | Coronavirus

As the COVID-19 pandemic emerged and spread around the world, the Department of Defense funded health surveillance activities to rapidly support military forces living and working in the U.S. and abroad. Armed Forces Health Surveillance Branch’s Global Emerging Infection Surveillance (GEIS) program manages a global laboratory network and uses analytical processes to detect emergent diseases and track respiratory illnesses such as influenza.

This GEIS-supported respiratory network, comprised of partnerships with Army, Navy, and Air Force public health and medical research laboratories, includes hundreds of surveillance sites in over 30 countries.

These surveillance locations are selected based on inputs from the regional laboratories and in coordination with the Geographic Combatant Commands. GEIS also funds and maintains surveillance of DoD Service members through the DoD Global Respiratory Pathogen Surveillance Program, which tests samples from over 100 sentinel site locations and is operated by the U.S. Air Force School of Aerospace Medicine. In addition, GEIS supports recruit and ship-board surveillance activities operated by Naval Health Research Center. Respiratory pathogens, bacteria and viruses that can cause diseases, present a unique challenge for recruit and ship-board populations due to their close living conditions and activities that can enable the rapid spread of infections and significantly impact force readiness.

“GEIS-funded surveillance provides the foundation for rapid testing so that a better understanding of the incidence and spread of SARS-CoV-2 virus can be established,” said U.S. Public Health Service Cmdr. (Dr.) Mark Scheckelhoff, lead for the GEIS Respiratory Infections portfolio. “Through the long-term investments to build and maintain this network of laboratory locations, we have an extensive analytical capability. GEIS has enabled our partners to respond to the ongoing pandemic and detect the presence of SARS-CoV-2 around the world.”

Through GEIS support, laboratory partners conduct many investigations including the sampling of animal markets and farm locations in four countries. These efforts include sampling of avian and swine species, as well as the workers at a particular location. Samples are then analyzed for novel influenza or other emerging pathogens with pandemic potential. 

Each laboratory within the network is able to perform highly sensitive and specific testing on respiratory samples and together process approximately 30,000 samples per year. These samples are collected in various clinics and military medical treatment facilities from individuals presenting with influenza-like-illness (ILI) symptoms.

“Due to the COVID-19 pandemic, the number of samples analyzed for the 2019-2020 season remains to be determined, but over 45,000 analytical tests on ILI samples have already been performed,” stated Army Lt. Col. (Dr.) Kevin Taylor, GEIS focus area chief.

GEIS coordinates closely with the Centers for Disease Control and Prevention and other partners to ensure the data is shared. They also present annual influenza data from DoD populations to the Food and Drug Administration, to help determine the composition of the seasonal influenza vaccine for the United States.

“GEIS coordinates information sharing activities related to the development of countermeasures, vaccines, and other interventions to support the ongoing pandemic and place the network in a good position to address future threats,” said Navy Capt. Guillermo Pimentel.

You also may be interested in...

COVID-19 Booster Shots

Infographic
8/27/2021
COVID-19 Booster Shots

If you have an immune system that is moderately to severely compromised, the CDC recommends you may receive an additional dose of mRNA COVID-19 vaccine (Pfizer or Moderna). This would be at least 4 weeks after your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Vaccine Eligibility | Coronavirus | COVID-19 Vaccine Efforts

Mask Guidance for Department of Defense Facilities

Infographic
7/30/2021
Mask Guidance for Department of Defense Facilities

In accordance with CDC guidance, the Department of Defense (DOD) requires all Service members, Federal employees, onsite contractor employees, and visitors, regardless of vaccination status, to wear a mask in all indoor DOD facilities. If you are not vaccinated, continue to physically distance consistent with applicable CDC and DOD Force Health Protection Guidance.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

The Delta Variant: Are You Protected?

Infographic
6/28/2021
The Delta Variant: Are You Protected?

Pfizer and Moderna vaccines are effective against the Delta Variant. If you've received your first dose, don't forget to get your second dose.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Delta Variant | Coronavirus | COVID-19 Vaccine Efforts

The Delta Variant

Infographic
6/28/2021
The Delta Variant

The Delta variant of the virus is a reason to get vaccinated. The variant is expanding, especially where vaccination rates are low.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Delta Variant | COVID-19 Vaccine Efforts | Coronavirus

The Delta Variant: Fact Check

Infographic
6/28/2021
The Delta Variant: Fact Check

The Delta variant of the virus is a reason to get vaccinated. This variant spreads easily, with increased rates of sickness and hospitalization.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Delta Variant | Coronavirus | COVID-19 Vaccine Efforts

The Delta Variant: Stop the Spread

Infographic
6/28/2021
The Delta Variant: Stop the Spread

The Delta variant is expanding, especially where vaccination rates are low. Visit www.tricare.mil/COVIDVaccine to learn more.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | COVID-19 Delta Variant | Coronavirus | COVID-19 Vaccine Efforts

COVID-19 Vaccination Card Second Shot

Infographic
5/27/2021
COVID-19 Vaccination Card Second Shot

Keep track of your vaccination card. Tips include keeping your card on you and taking a picture of it as a backup copy.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Costs and Documentation | Coronavirus

Is It Allergies or COVID-19?

Infographic
5/11/2021
Is It Allergies or COVID-19?

This Infographic provides a chart that outlines how to tell the difference between COVID-19 and allergy symptoms

Recommended Content:

Symptoms of COVID-19 | Coronavirus | Coronavirus and the COVID-19 Vaccine

VAX Fact Breastfeeding

Infographic
4/19/2021
VAX Fact Breastfeeding

An infographic answering the question of whether you can get the COVID-19 vaccine if you're breastfeeding.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Other Medical Conditions

Infographic
4/19/2021
VAX Fact Other Medical Conditions

An infographic answering the question of whether you can get the COVID-19 vaccine if you have underlying medical conditions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Currently Pregnant

Infographic
4/19/2021
VAX Fact Currently Pregnant

An infographic answering the question of whether to get the COVID-19 vaccine if you're currently pregnant.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Protection Last

Infographic
4/19/2021
VAX Fact Protection Last

An infographic answering the question of how long the COVID-19 vaccine protection lasts.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Current Infection

Infographic
4/19/2021
VAX Fact Current Infection

An infographic answering the question of whether to get the COVID-19 vaccine if you currently have a positive COVID-19 infection.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

VAX Fact Affect Fertility

Infographic
4/19/2021
VAX Fact Affect Fertility

An infographic answering the question of whether the COVID-19 vaccine affects a person's fertility.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Is It Your Time to Get the COVID-19 Vaccine?

Infographic
3/5/2021
Is It Your Time to Get the COVID-19 Vaccine?

This Infographic informs TRICARE beneficiaries which tier they fall into as their local military treatment facility or clinic offers the vaccine.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 7

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.